Karin Mörl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Karin Mörl has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Annette Gabriele Beck‐Sickinger
Institute of Biochemistry Leipzig University Leipzig Germany
5 shared publications Beili Wu
State Key Laboratory of Drug Research State Key Laboratory of Chemical Biology Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China
2 shared publications- Hongyu Wang
School of Pharmacy Fudan University Shanghai China
2 shared publications - Kristin Löbner
Institute of Biochemistry Leipzig University Leipzig Germany
2 shared publications Kun Chen
State Key Laboratory of Drug Research State Key Laboratory of Chemical Biology Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China
2 shared publications- Lisa Christin Peuker
Institute of Biochemistry Leipzig University Leipzig Germany
2 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Wiley in Angewandte Chemie International Edition
- p. e4104254
Molecular Basis of NPY Recognition and Ligand Selectivity at the Neuropeptide Y 5 Receptor
Neuropeptide Y receptors (YRs) have been demonstrated to mediate physiological functions such as food intake, energy expenditure and mood regulation. Despite the low sequence identity exhibited by the four YR subtypes, Y 1 R, Y 2 R, Y 4 R, and Y 5 R, all of them recognize the endogenous ligand neuropeptide Y (NPY), which demonstrates their complex ligand recognition and activation mechanisms. The Y 5 R is regarded as a promising drug target for cachexia and cancer, but drug development has been hampered by the lack of structural information on ligand‐Y 5 R interactions. We report the cryo‐electron microscopy structure of Y 5 R in complex with NPY and the G i1 protein, revealing unique features of the Y 5 R extracellular regions that participate in ligand recognition and illustrating the specific binding mode of the NPY C‐terminus to Y 5 R. The structural information is supported by mutagenesis studies investigating ligand binding and receptor activation with the endogenous ligand NPY and the selective Y 5 R agonist sY 5 ago. Structural analysis provides valuable insights into the factors driving receptor subtype selectivity, thus offering an opportunity for drug discovery of Y 5 R.
- 28 October 2026
- Published by Wiley in Angewandte Chemie International Edition
- p. e4104254
Open AccessMolecular Basis of NPY Recognition and Ligand Selectivity at the Neuropeptide Y 5 Receptor
Neuropeptide Y receptors (YRs) have been demonstrated to mediate physiological functions such as food intake, energy expenditure and mood regulation. Despite the low sequence identity exhibited by the four YR subtypes, Y 1 R, Y 2 R, Y 4 R, and Y 5 R, all of them recognize the endogenous ligand neuropeptide Y (NPY), which demonstrates their complex ligand recognition and activation mechanisms. The Y 5 R is regarded as a promising drug target for cachexia and cancer, but drug development has been hampered by the lack of structural information on ligand‐Y 5 R interactions. We report the cryo‐electron microscopy structure of Y 5 R in complex with NPY and the G i1 protein, revealing unique features of the Y 5 R extracellular regions that participate in ligand recognition and illustrating the specific binding mode of the NPY C‐terminus to Y 5 R. The structural information is supported by mutagenesis studies investigating ligand binding and receptor activation with the endogenous ligand NPY and the selective Y 5 R agonist sY 5 ago. Structural analysis provides valuable insights into the factors driving receptor subtype selectivity, thus offering an opportunity for drug discovery of Y 5 R.
- Open Access
- 28 October 2026
- Published by Wiley in Angewandte Chemie
Molecular Basis of NPY Recognition and Ligand Selectivity at the Neuropeptide Y 5 Receptor
Neuropeptide Y receptors (YRs) have been demonstrated to mediate physiological functions such as food intake, energy expenditure and mood regulation. Despite the low sequence identity exhibited by the four YR subtypes, Y 1 R, Y 2 R, Y 4 R, and Y 5 R, all of them recognize the endogenous ligand neuropeptide Y (NPY), which demonstrates their complex ligand recognition and activation mechanisms. The Y 5 R is regarded as a promising drug target for cachexia and cancer, but drug development has been hampered by the lack of structural information on ligand‐Y 5 R interactions. We report the cryo‐electron microscopy structure of Y 5 R in complex with NPY and the G i1 protein, revealing unique features of the Y 5 R extracellular regions that participate in ligand recognition and illustrating the specific binding mode of the NPY C‐terminus to Y 5 R. The structural information is supported by mutagenesis studies investigating ligand binding and receptor activation with the endogenous ligand NPY and the selective Y 5 R agonist sY 5 ago. Structural analysis provides valuable insights into the factors driving receptor subtype selectivity, thus offering an opportunity for drug discovery of Y 5 R.
- 28 October 2026
- Published by Wiley in Angewandte Chemie
Open AccessMolecular Basis of NPY Recognition and Ligand Selectivity at the Neuropeptide Y 5 Receptor
Neuropeptide Y receptors (YRs) have been demonstrated to mediate physiological functions such as food intake, energy expenditure and mood regulation. Despite the low sequence identity exhibited by the four YR subtypes, Y 1 R, Y 2 R, Y 4 R, and Y 5 R, all of them recognize the endogenous ligand neuropeptide Y (NPY), which demonstrates their complex ligand recognition and activation mechanisms. The Y 5 R is regarded as a promising drug target for cachexia and cancer, but drug development has been hampered by the lack of structural information on ligand‐Y 5 R interactions. We report the cryo‐electron microscopy structure of Y 5 R in complex with NPY and the G i1 protein, revealing unique features of the Y 5 R extracellular regions that participate in ligand recognition and illustrating the specific binding mode of the NPY C‐terminus to Y 5 R. The structural information is supported by mutagenesis studies investigating ligand binding and receptor activation with the endogenous ligand NPY and the selective Y 5 R agonist sY 5 ago. Structural analysis provides valuable insights into the factors driving receptor subtype selectivity, thus offering an opportunity for drug discovery of Y 5 R.
- Open Access
- 7 June 2025
- Published by Elsevier in Materials Today Bio
- Vol. 33, 101958
Bio-inspired biomaterial coating for enzyme responsive release of antimicrobial peptides
- 7 June 2025
- Published by Elsevier in Materials Today Bio
- Vol. 33, 101958
Open AccessBio-inspired biomaterial coating for enzyme responsive release of antimicrobial peptides
- Open Access
- 9 August 2023
- Published by Wiley in ChemBioChem
- Vol. 24 (18) , e202300280
Stable Binding of Full‐Length Chemerin Is Driven by Negative Charges in the CMKLR1 N Terminus
The adipokine chemerin is the endogenous ligand of the chemokine‐like receptor 1 (CMKLR1), a member of the family of G protein‐coupled receptors (GPCRs). This protein ligand plays an important role in obesity and inflammatory processes. Stable receptor–ligand interactions are highly relevant for its different physiological effects such as the migration of immune cells towards sites of inflammation. Here, we demonstrate that negative charges in the CMKLR1 N terminus are involved in the formation of strong contacts with a specific positively charged patch at the surface of full‐length chemerin, which is absent in the short nonapeptide agonist chemerin‐9, thus explaining its reduced affinity. Using receptor chimera of G protein‐coupled receptor 1 (GPR1) and CMKLR1, we were able to identify the residues of this interaction and its relevance for stable full‐length chemerin binding. This could help to develop more potent ligands for the treatment of inflammation‐related diseases.
- 9 August 2023
- Published by Wiley in ChemBioChem
- Vol. 24 (18) , e202300280
Open AccessStable Binding of Full‐Length Chemerin Is Driven by Negative Charges in the CMKLR1 N Terminus
The adipokine chemerin is the endogenous ligand of the chemokine‐like receptor 1 (CMKLR1), a member of the family of G protein‐coupled receptors (GPCRs). This protein ligand plays an important role in obesity and inflammatory processes. Stable receptor–ligand interactions are highly relevant for its different physiological effects such as the migration of immune cells towards sites of inflammation. Here, we demonstrate that negative charges in the CMKLR1 N terminus are involved in the formation of strong contacts with a specific positively charged patch at the surface of full‐length chemerin, which is absent in the short nonapeptide agonist chemerin‐9, thus explaining its reduced affinity. Using receptor chimera of G protein‐coupled receptor 1 (GPR1) and CMKLR1, we were able to identify the residues of this interaction and its relevance for stable full‐length chemerin binding. This could help to develop more potent ligands for the treatment of inflammation‐related diseases.
- Open Access
- 6 May 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (18) , eabm1232
Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors
In response to three highly conserved neuropeptides, neuropeptide Y (NPY), peptide YY, and pancreatic polypeptide (PP), four G protein–coupled receptors mediate multiple essential physiological processes, such as food intake, vasoconstriction, sedation, and memory retention. Here, we report the structures of the human Y 1 , Y 2 , and Y 4 receptors in complex with NPY or PP, and the G i1 protein. These structures reveal distinct binding poses of the peptide upon coupling to different receptors, reflecting the importance of the conformational plasticity of the peptide in recognizing the NPY receptors. The N terminus of the peptide forms extensive interactions with the Y 1 receptor, but not with the Y 2 and Y 4 receptors. Supported by mutagenesis and functional studies, subtype-specific interactions between the receptors and peptides were further observed. These findings provide insight into key factors that govern NPY signal recognition and transduction, and would enable development of selective drugs.
- 6 May 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (18) , eabm1232
Open AccessReceptor-specific recognition of NPY peptides revealed by structures of NPY receptors
In response to three highly conserved neuropeptides, neuropeptide Y (NPY), peptide YY, and pancreatic polypeptide (PP), four G protein–coupled receptors mediate multiple essential physiological processes, such as food intake, vasoconstriction, sedation, and memory retention. Here, we report the structures of the human Y 1 , Y 2 , and Y 4 receptors in complex with NPY or PP, and the G i1 protein. These structures reveal distinct binding poses of the peptide upon coupling to different receptors, reflecting the importance of the conformational plasticity of the peptide in recognizing the NPY receptors. The N terminus of the peptide forms extensive interactions with the Y 1 receptor, but not with the Y 2 and Y 4 receptors. Supported by mutagenesis and functional studies, subtype-specific interactions between the receptors and peptides were further observed. These findings provide insight into key factors that govern NPY signal recognition and transduction, and would enable development of selective drugs.